Domov › Limfom › North Carolina › Durham
Klinične študije za Limfom v Durham, NC
17 študij za Limfom išče udeležence na lokacijah v Durham in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Vključevanje udeležencevFaza 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi stran
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Vključevanje udeležencevFaza 2
- Duke University, Durham
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Vključevanje udeležencevFaza 1/2
- Duke University Medical Center, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Vključevanje udeležencevFaza 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 mi stran
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Vključevanje udeležencev
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi stran
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Vključevanje udeležencevFaza 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi stran
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Vključevanje udeležencevFaza 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
Vključevanje udeležencevFaza 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Vključevanje udeležencevFaza 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Vključevanje udeležencev
- North Carolina Basnight Cancer Hospital, Chapel Hill · 10 mi stran
Registry of Older Patients With Cancer
Vključevanje udeležencevOpazovalna študija
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi stran
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Vključevanje udeležencevFaza 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Vključevanje udeležencevFaza 2
- University of North Carolina, Chapel Hill · 10 mi stran
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Vključevanje udeležencev
- Duke Cancer Institute, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Vključevanje udeležencevFaza 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi stran
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Vključevanje udeležencevOpazovalna študija
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi stran
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Vključevanje udeležencevFaza 2
- Durham VA Medical Center, Durham, NC, Durham
Študije za Limfom v drugih mestih
- Houston, TX34 študij
- Boston, MA33 študij
- New York City, NY33 študij
- Washington, DC23 študij
- Baldwin Park, CA21 študij
- Chicago, IL20 študij
- St. Louis, MO15 študij
- Philadelphia, PA15 študij
- Cleveland, OH14 študij
- Edison, NJ12 študij
- Atlanta, GA12 študij
- Seattle, WA12 študij
Druge študije v Durham
- Rak dojke63 študij
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak39 študij
- Množni mielom37 študij
- Metastatski rak33 študij
- Akutna mieločna levkemija33 študij
- Rak pljuč32 študij
- Rak prostate32 študij
- Kolorektalni rak28 študij
- Kronična limfocitna levkemija27 študij
- Rak jajčnikov27 študij
- Srčno popuščanje26 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.